Your browser doesn't support javascript.
loading
Ganglioside GM3 and Its Role in Cancer.
Zheng, Changping; Terreni, Marco; Sollogoub, Matthieu; Zhang, Yongmin.
Affiliation
  • Zheng C; Sorbonne Universite, CNRS, Institut Parisien de Chimie Moleculaire (UMR 8232), 4 Place Jussieu, 75005 Paris, France.
  • Terreni M; Drug Sciences Department, University of Pavia, Viale Taramelli 12, 27100 Pavia, Italy.
  • Sollogoub M; Sorbonne Universite, CNRS, Institut Parisien de Chimie Moleculaire (UMR 8232), 4 Place Jussieu, 75005 Paris, France.
  • Zhang Y; Sorbonne Universite, CNRS, Institut Parisien de Chimie Moleculaire (UMR 8232), 4 Place Jussieu, 75005 Paris, France.
Curr Med Chem ; 26(16): 2933-2947, 2019.
Article in En | MEDLINE | ID: mdl-29376491
ABSTRACT
Ganglioside GM3 is strongly related with human tumors, such as lung, brain cancers and melanomas, and more and more evidences have revealed that GM3 possesses powerful effects on cancer development and progression. GM3 is over expressed on several types of cancers, and can be as a tumor-associated carbohydrate antigen, used for immunotherapy of cancers. GM3 can also inhibit tumor cells growth by anti-angiogenesis or motility and so on. Especially, GM3 has effects on the EGFR tyrosine kinase signaling, uPAR-related signaling and glycolipid-enriched microdomains, which are essential for cancer signaling conduction. It is obvious that GM3 will be a promising target for cancer treatment.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: G(M3) Ganglioside / Neoplasms Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2019 Document type: Article Affiliation country: France

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: G(M3) Ganglioside / Neoplasms Limits: Animals / Humans Language: En Journal: Curr Med Chem Journal subject: QUIMICA Year: 2019 Document type: Article Affiliation country: France